Amgen Neupogen Injection Recall: Stability Issues Before Expiry

Take action

Contact the company & request your remedy

Recalling firmAmgen, Inc.1 Amgen Center Dr, N/A · Thousand Oaks, CA 91320-1730

No email on file — write to the address above instead.

✎ GovInfoNow plain-language explainer

What happened, in plain English

Amgen is recalling certain Neupogen (filgrastim) injection vials because they may lose stability before the 36-month expiry date. This could mean the medication is no longer effective or safe when the vial expires.

Why it’s dangerous

The stability data shows the product might not meet quality standards by its 36-month expiry date. This could lead to the medication being ineffective or unsafe when the vial expires.

Who’s affected

Patients prescribed Neupogen injections by a doctor who own the recalled vials or boxes. Those with the specific lot numbers and expiration dates listed are most at risk.

How to tell if you have this one

Check the vial or box for the lot numbers: 1147308, 1154183 (expiring 2/28/2025), 1156807, 1160222 (expiring 6/30/2025), 1160223, 1163912, 1167352 (expiring 2/28/2026), or 1171365, 1175057, 1176250 (expiring 11/30/2026).

Brand
Amgen
Category
Drug

Based on the official FDA remedy

What to do — step by step

Check Vial Expiry
Look for the lot numbers and expiration dates on the vial or box to confirm if it is in the recalled list.

✎ GovInfoNow

Questions people ask

Why is this product being recalled?

The product may become unstable before its 36-month expiry date, potentially making it ineffective or unsafe.

What should I do if I have the recalled product?

The recall record does not specify a remedy, so contact your doctor or pharmacist for guidance.

How can I tell if my vial is recalled?

Check the lot numbers: 1147308, 1154183 (expiring 2/28/2025), 1156807, 1160222 (expiring 6/30/2025), 1160223, 1163912, 1167352 (expiring 2/28/2026), or 1171365, 1175057, 1176250 (expiring 11/30/2026).

Take action

Contact Amgen

We’ve drafted a message you can send Amgen to request your refund or repair — edit it as you like.

✉️ Open in email

Subject: Recall D-0286-2025 — Amgen Amgen

Hello,

I own a Amgen that is covered by recall D-0286-2025 from Amgen.

I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this?

Thank you.

Similar recalls

From people who’ve dealt with this

Experiences, tips, and questions from readers. Every comment is reviewed before it appears.

No comments yet — be the first to share your experience.

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

Official source: FDA Recall #D-0286-2025 (February 27, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0286-2025 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.

Amgen, Inc. recalls Neupogen (filgrastim) For Injection, 480 mcg/1.6 mL (300 mcg/1 mL), 1.6 mL single Dose Vial, Rx Only, For Subcutaneous

Lower-risk recall